text: Cost-effectiveness of<unk>  focuses on the use of balance of medical expenses and<unk> utic efficacy. In the case of GvHD<unk> , corticosteroids are the least expensive treatment option, and alternative immunosuppressants or biologics are more expensive.
option_0: Graft-versus-host disease cost-effectiveness of therapy
option_1: Multi-drug-resistant tuberculosis cost-effectiveness of therapy
option_2: Gangrene cost-effectiveness of therapy
option_3: Minimal change disease cost-effectiveness of therapy
option_4: Graft-versus-host disease future or investigational therapies
option_5: Trench mouth cost-effectiveness of therapy
option_6: Osteoporosis cost-effectiveness of therapy
option_7: Pneumoconiosis cost-effectiveness of therapy